Company Info

Arranta Bio

CDMO

Overview

Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies. Our dedicated team, state-of-the-art facilities, and unparalleled resources are crucial for advancing products from development to commercial launch. Arranta Bio continues to expand capacity and development and manufacturing services across multiple sites with technology platforms designed to meet the evolving demands of our clients and partners.

Contributors

Doug Kennedy

Nicole O’Brien, Ph.D.

Jeff Heiser

Melanie Cerullo

Susan Surabian

Dave Stevens

Aaron B. Cowley, Ph.D.

Michael Wourms

Mark Bamforth

Contributions

Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand its Biologics Offering in the U.S.

Presenting an Integrated Solution for mRNA Vaccine Manufacturing

Serving an Accelerated Market with mRNA Production

Investing in mRNA Production

Limiting Risk In mRNA Development and Production

Integrating a Fragmented mRNA Supply Chain

Arranta Bio Announces Completion of Sale of Florida Site and Progress on $150M Investment Plan to Expand Development and Commercial Manufacturing Services

Integrated Support Facilitates mRNA Product Development and Commercialization

Enabling the Commercialization of Microbiome Live Biotherapeutic Products with Fit-for-Purpose Cryopreservatives

Arranta Bio Announces First End-to-End Manufacturing for mRNA Vaccines in its Commercial-Ready GMP Facility

About Us

That's Nice Staffing

More

Media Kit Donwload Current Issue

Your Account

Help

Contact Us Support

Nice Insight/That’s Nice

89 Fifth Avenue
Fifth Floor
New York
NY 10003-3020

New York – San Diego – Chicago
London – Frankfurt – Shanghai

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.